DexCom Inc.

DXCM ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-53.5M
Depreciation & Amortization $2.4M
Depreciation
Amortization
Stock-Based Compensation $8.4M
Net Cash from Operating Activities $-39.4M
Investing Activities
Capital Expenditures $3.0M
Business Acquisitions
Net Cash from Investing Activities $-14.1M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $44.4M
Net Change in Cash $-9.1M
Free Cash Flow $-42.4M
← Newer Page 3 of 3 Older →